Oct 19, 2021 9:00am EDT Peer-Reviewed Article Confirms That Qualigen’s FastPack® is as Accurate in Thyroid Stimulating Hormone Measurement -- and Much Faster -- Than a Leading Laboratory Method
Sep 15, 2021 7:30am EDT Qualigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 08, 2021 7:30am EDT Qualigen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 17, 2021 8:00am EDT Qualigen Therapeutics, Inc. Provides Update on Product Development Priorities and Reports Second Quarter and Six Month 2021 Financial Results
Jul 14, 2021 7:30am EDT Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19
Jun 02, 2021 7:30am EDT Qualigen Therapeutics, Inc. to Present at the LD Micro Invitational XI Conference
May 19, 2021 7:30am EDT Qualigen Therapeutics, Inc. Appoints Tariq Arshad, MD, MBA as Chief Medical Officer
May 14, 2021 1:35pm EDT Qualigen Therapeutics, Inc. Reports First Quarter 2021 Financial Results and Provides Corporate Update
Mar 18, 2021 8:30am EDT Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference
